$0.76 -$0.02 (-3.1%)

04:00 PM EDT on 08/23/19

Second Sight Medical Products (NASDAQ:EYES)

CAPS Rating: 1 out of 5

Current Price $0.76 Mkt Cap $109.6M
Open $0.78 P/E Ratio 0.00
Prev. Close $0.78 Div. (Yield) $0.00 (0.0%)
Daily Range $0.73 - $0.78 Volume 121,147
52-Wk Range $0.64 - $1.20 Avg. Daily Vol.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

18 Outperform
9 Underperform
 

All-Star Players

1 Outperform
8 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NASDAQ:EYES Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dlcarden (41.86)
Submitted November 29, 2014

This one's a gamble in every sense of the word, but EYES develops disruptive technologies with little-to-no competition. I keep hearing $35 being batted around as the target price but if they succeed the stock will soar like Google and Amazon. 3 to 5… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:EYES VS S&P 500 (SPY)

NASDAQ:EYES Summary

Fools bullish on NASDAQ:EYES are also bullish on:

Fools bearish on NASDAQ:EYES are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EYES.

Recs

0
Member Avatar msj1819 (< 20) Submitted: 7/29/2015 2:42:17 PM : Outperform Start Price: $13.92 NASDAQ:EYES Score: -129.66

Once their Argus product line hits larger distribution for both retinitis pigmentosa and, newly announced as effective for macular degeneration, the market penetration becomes much broader, production costs at volume will go down, and people will recognize the value of the stock as well as its products.

Recs

0
Member Avatar TurbulentTime (24.82) Submitted: 7/17/2015 6:07:10 AM : Outperform Start Price: $14.75 NASDAQ:EYES Score: -128.96

It has real results, patients regain eyesight. Newer version is under testing phrase and is expected to do a much better job and gain wider acceptance and traction for implants.

Recs

0
Member Avatar manirg (< 20) Submitted: 3/27/2015 2:53:31 PM : Outperform Start Price: $12.75 NASDAQ:EYES Score: -131.44

Has a proven and working technology. Undervalued at ~$13, potential $24 in a year or so.............

Leaderboard

Find the members with the highest scoring picks in EYES.

Score Leader

glenn12345

glenn12345 (99.99) Score: +370.25

The Score Leader is the player with the highest score across all their picks in EYES.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
FunesDMemorious 98.51 2/24/2016 Underperform 5Y $6.49 -88.34% +49.29% +137.63 0 Comment
constructive 99.96 8/7/2017 Underperform 5Y $1.15 -34.26% +14.90% +49.16 0 Comment
cashsage 99.05 12/19/2018 Underperform 5Y $0.84 -9.47% +10.27% +19.74 0 Comment
Strawfidl 58.43 2/4/2019 Underperform 5Y $0.79 -3.82% +5.39% +9.21 0 Comment
whatsthepoint 99.98 3/8/2019 Underperform 5Y $0.76 -0.53% +4.29% +4.82 0 Comment
acekeldog 99.70 3/28/2019 Underperform 3M $0.77 -1.78% +1.32% +3.10 0 Comment
dusand 99.81 2/8/2019 Underperform 5Y $0.71 +6.40% +5.85% -0.55 0 Comment
glenn12345 99.99 2/28/2019 Underperform 5Y $0.67 +12.47% +2.11% -10.36 0 Comment
rduchesn < 20 3/15/2018 Outperform 5Y $1.96 -61.43% +3.18% -64.61 0 Comment
jeffaim 97.71 10/24/2016 Outperform 3Y $2.85 -73.47% +32.54% -106.02 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCharlesPayn < 20 3/6/2015 Outperform 3M $17.44 -95.67% +37.79% -133.46 0 Comment
TrackJimCramer 86.36 12/23/2014 Underperform 3W $10.15 -92.55% +37.02% +129.57 0 Comment